The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?
Breast cancer is one of the leading malignant tumors that endanger women’s health worldwide. Despite the rapid progress on the therapies, including chemotherapy, surgical resection, and other auxiliary methods, there were still numerous people died of breast cancer, which promoted the researchers to...
Main Authors: | Qingqing Ou, Jiang Cheng, Licui Zhang, Huimin Wang, Wei Wang, Yajing Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-06-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317706214 |
Similar Items
-
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
by: Dongjie Seng, et al.
Published: (2019-05-01) -
Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma
by: Siqian Wang, et al.
Published: (2018-01-01) -
Breast cancer prognostication with neutrophil–lymphocyte ratio and platelet–lymphocyte ratio
by: Taha Bahgat
Published: (2017-01-01) -
Prognostic Relevance of Pretreatment Peripheral Neutrophil Count and Neutrophil-to-lymphocyte Ratio in Primary Cutaneous Angiosarcoma
by: Kentaro Awaji, et al.
Published: (2021-08-01) -
Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
by: Najjar M, et al.
Published: (2018-01-01)